Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AXERA Access Safety and Efficacy Post Endovascular INtervention

NCT01773148 is registered in ClinicalTrials.gov with Arstasis, Inc. as lead sponsor.

NCT NCT01773148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01773148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AXERA Access Safety and Efficacy Post Endovascular INtervention
Lead sponsor
Arstasis, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2012
Completion date
June 30, 2015
Enrollment
240 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease.